BSW Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$843K Buy
14,637
+1,246
+9% +$71.5K 0.09% 121
2026
Q1
$812K Buy
13,391
+2,453
+22% +$143K 0.1% 121
2025
Q4
$590K Sell
10,938
-349
-3% -$16.8K 0.07% 158
2025
Q3
$509K Buy
11,287
+4,077
+57% +$190K 0.06% 172
2025
Q2
$334K Sell
7,210
-1,130
-14% -$55.5K 0.05% 225
2025
Q1
$509K Sell
8,340
-1,200
-13% -$69.9K 0.08% 151
2024
Q4
$540K Buy
9,540
+1,361
+17% +$76K 0.08% 146
2024
Q3
$423K Sell
8,179
-713
-8% -$33.4K 0.06% 182
2024
Q2
$369K Buy
8,892
+641
+8% +$28.7K 0.06% 174
2024
Q1
$447K Sell
8,251
-648
-7% -$33K 0.08% 150
2023
Q4
$457K Buy
8,899
+1,398
+19% +$73.4K 0.09% 132
2023
Q3
$435K Sell
7,501
-1,141
-13% -$69.9K 0.1% 126
2023
Q2
$553K Sell
8,642
-209
-2% -$14K 0.12% 102
2023
Q1
$613K Buy
8,851
+334
+4% +$23.6K 0.13% 113
2022
Q4
$613K Buy
8,517
+887
+12% +$66.9K 0.13% 116
2022
Q3
$542K Buy
7,630
+4
+0.1% +$290 0.13% 107
2022
Q2
$587K Buy
7,626
+129
+2% +$9.82K 0.14% 108
2022
Q1
$548K Buy
7,497
+398
+6% +$26.7K 0.14% 113
2021
Q4
$443K Buy
7,099
+1,351
+24% +$79.3K 0.11% 136
2021
Q3
$340K Sell
5,748
-3,574
-38% -$235K 0.1% 156
2021
Q2
$623K Sell
9,322
-236
-2% -$15.4K 0.17% 80
2021
Q1
$603K Sell
9,558
-1,323
-12% -$82.3K 0.17% 74
2020
Q4
$675K Buy
10,881
+4,678
+75% +$288K 0.21% 60
2020
Q3
$374K Sell
6,203
-2,165
-26% -$130K 0.14% 87
2020
Q2
$492K Buy
8,368
+434
+5% +$26K 0.16% 65
2020
Q1
$442K Sell
7,934
-44
-0.6% -$2.69K 0.18% 57
2019
Q4
$512K Buy
7,978
+2,035
+34% +$117K 0.17% 57
2019
Q3
$301K Buy
5,943
+431
+8% +$20.3K 0.12% 75
2019
Q2
$250K Buy
5,512
+1,242
+29% +$57.9K 0.09% 86
2019
Q1
$204K Buy
4,270
+28
+0.7% +$1.4K 0.08% 88
2018
Q4
$221K Buy
4,242
+242
+6% +$13K 0.08% 78
2018
Q3
$248K Sell
4,000
-1,331
-25% -$79K 0.09% 106
2018
Q2
$295K Buy
5,331
+322
+6% +$17.4K 0.13% 65
2018
Q1
$317K Sell
5,009
-183
-4% -$11.8K 0.14% 60
2017
Q4
$318K Sell
5,192
-190
-4% -$11.9K 0.13% 63
2017
Q3
$343K Buy
5,382
+274
+5% +$16K 0.15% 54
2017
Q2
$285K Buy
+5,108
New +$278K 0.13% 60
2015
Q4
Sell
-4,062
Closed -$240K 65
2015
Q3
$240K Buy
4,062
+3
+0.1% +$190 0.14% 53
2015
Q2
$270K Buy
+4,059
New +$267K 0.17% 49

Other funds holding BMY

BSW Wealth Partners's BMY Position: Q2 2026 in Review

BSW Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 9.3% in Q2 2026, buying an estimated $71.5K and bringing the position to 14,637 shares worth $843K. The position accounts for 0.09% of the portfolio, ranked #121.

BSW Wealth Partners first reported a position in BMY in Q2 2015 and has held it in 39 quarters since. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • BSW Wealth Partners held 14,637 shares of Bristol-Myers Squibb worth $843K as of Q2 2026.
  • BSW Wealth Partners bought 1,246 Bristol-Myers Squibb shares in Q2 2026, an estimated $71.5K.
  • Bristol-Myers Squibb made up 0.09% of BSW Wealth Partners's portfolio in Q2 2026, its #121 holding.
  • BSW Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 39 quarters since.
  • 954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.